scispace - formally typeset
J

Jens Wiltfang

Researcher at University of Göttingen

Publications -  637
Citations -  29875

Jens Wiltfang is an academic researcher from University of Göttingen. The author has contributed to research in topics: Dementia & Medicine. The author has an hindex of 75, co-authored 538 publications receiving 25886 citations. Previous affiliations of Jens Wiltfang include University of Erlangen-Nuremberg & Max Planck Society.

Papers
More filters
Journal ArticleDOI

Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease

Denise Harold, +86 more
- 01 Oct 2009 - 
TL;DR: A two-stage genome-wide association study of Alzheimer's disease involving over 16,000 individuals, the most powerful AD GWAS to date, produced compelling evidence for association with Alzheimer's Disease in the combined dataset.
Journal ArticleDOI

Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease.

Paul Hollingworth, +177 more
- 01 May 2011 - 
TL;DR: Meta-analyses of all data provided compelling evidence that ABCA7 and the MS4A gene cluster are new Alzheimer's disease susceptibility loci and independent evidence for association for three loci reported by the ADGC, which, when combined, showed genome-wide significance.
Journal ArticleDOI

Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimertextquotesingles disease

TL;DR: A two-stage genome-wide association study of Alzheimer's disease involving over 16,000 individuals, the most powerful AD GWAS to date, produced compelling evidence for association with Alzheimer’s disease in the combined dataset.
Journal ArticleDOI

Improved discrimination of AD patients using beta-amyloid((1-42)) and tau levels in CSF

TL;DR: The combined measure of CSF Aβ42 and tau meets the requirements for clinical use in discriminating AD from normal aging and specific neurologic disorders.
Journal ArticleDOI

Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's disease.

Lesley Jones, +82 more
- 15 Nov 2010 - 
TL;DR: Independent evidence from two large studies demonstrates that these processes related to cholesterol metabolism and the innate immune response are aetiologically relevant, and suggests that they may be suitable targets for novel and existing therapeutic approaches.